SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RXGOLF who wrote (630)4/21/1998 10:49:00 PM
From: Sleepman  Read Replies (1) of 834
 
Dr. Golf:
I like this company and actually got in just prior to the fanfare from the NBR mention.
I think that this is interesting because they will, if approved, have the only thrombin inhibitor on the market. From talking with other MDs, I think that this class of anticoagulants will be leaders in the field--without some of the problems of heparin, and with a risk profile similar to low molecular weight heparin.
Also, the heart failure product is intreguing. Good luck. Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News